Acute stroke: Postprocedural care and management of complications

Techniques in Vascular and Interventional Radiology

Volumn 15, Issue 1, 2012, Pages 78-86

  De Carvalho, Flávio Augusto ^a,b   De Figueiredo, Marcelo Marinho ^a   Silva, Gisele Sampaio ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Acute stroke; Endovascular treatment; Neurocritical care; Postprocedural care

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALTEPLASE; AMINOCAPROIC ACID; CLOPIDOGREL; GLUCOSE; INSULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MIDAZOLAM; NICARDIPINE; NITROPRUSSIDE SODIUM; PROPOFOL; PROTAMINE SULFATE; THROMBIN; TRANEXAMIC ACID;

ANTIHYPERTENSIVE THERAPY; ARTERY DISSECTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BODY TEMPERATURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTRAST INDUCED NEPHROPATHY; DEEP VEIN THROMBOSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG HALF LIFE; ENDOTRACHEAL INTUBATION; ENDOVASCULAR SURGERY; FALSE ANEURYSM; FEMORAL ARTERY; FOLLOW UP; HEMATOMA; HEMODYNAMIC MONITORING; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; IN-STENT RESTENOSIS; INSULIN TREATMENT; INTENSIVE CARE; INTRACRANIAL PRESSURE; LENGTH OF STAY; LIMB ISCHEMIA; MEDICAL EDUCATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; REPERFUSION INJURY; RETROPERITONEAL HEMORRHAGE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; VASCULAR ACCESS;

BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; HUMANS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; STROKE; TREATMENT OUTCOME;

EID: 84859034052     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2011.12.005     Document Type: Article

References (68)

1. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group.
2. Kleindorfer D., Kissela B., Schneider A., et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004, 35:e27-e29.
3. Heuschmann P.U., Berger K., Misselwitz B., et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality. Stroke 2003, 34:1106-1113. The German Stroke Registers Study Group.
4. Christou I., Burgin W.S., Alexandrov A.V., et al. Arterial status after intravenous tpa therapy for ischaemic stroke: A need for further interventions. Int Angiol 2001, 20:208-213.
5. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The proact II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999, 282:2003-2011.
6. Smith W.S., Sung G., Saver J., et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the multi merci trial. Stroke 2008, 39:1205-1212.
7. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40:2761-2768. Penumbra Pivotal Stroke Trial Investigators.
8. Ogawa A., Mori E., Minematsu K., et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007, 38:2633-2639.
9. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the merci trial. Stroke 2005, 36:1432-1438.
10. Tarr R., Hsu D., Kulcsar Z., Bonvin C., et al. The POST trial: Initial post-market experience of the penumbra system: Revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg 2010, 2:341-344.
11. Castaño C., Dorado L., Guerrero C., et al. Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: A pilot study. Stroke 2010, 41:1836-1840.
12. Brekenfeld C., Schroth G., El-Koussy M., et al. Mechanical thromboembolectomy for acute ischemic stroke: Comparison of the catch thrombectomy device and the merci retriever in vivo. Stroke 2008, 39:1213-1219.
13. Henkes H., Reinartz J., Lowens S., et al. A device for fast mechanical clot retrieval from intracranial arteries (phenox clot retriever). Neurocrit Care 2006, 5:134-140.
14. Nakano S., Iseda T., Yoneyama T., et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: An alternative option to intra-arterial thrombolysis. Stroke 2002, 33:2872-2876.
15. Leary M.C., Saver J.L., Gobin Y.P., et al. Beyond tissue plasminogen activator: Mechanical intervention in acute stroke. Ann Emerg Med 2003, 41:838-846.
16. Zaidat O.O., Wolfe T., Hussain S.I., et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008, 39:2392-2395.
17. Nguyen T.N., Babikian V.L., Romero R., et al. Intra-arterial treatment methods in acute stroke therapy. Front Neurol 2011, 2:9.
18. Suarez J.I. Outcome in neurocritical care: Advances in monitoring and treatment and effect of a specialized neurocritical care team. Crit Care Med 2006, 34:S232-S238.
19. Mirski M.A., Chang C.W., Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: Evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol 2001, 13:83-92.
20. Hutchens M.P., Memtsoudis S., Sadovnikoff N. Propofol for sedation in neuro-intensive care. Neurocrit Care 2006, 4:54-62.
21. Oliveira-Filho J., Silva S.C., Trabuco C.C., et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003, 61:1047-1051.
22. Potter J.F., Robinson T.G., Ford G.A., et al. Controlling hypertension and hypotension immediately post-stroke (Chhips): A randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009, 8:48-56.
23. Hankey G.J. Lowering blood pressure in acute stroke: The SCAST trial. Lancet 2011, 377:696-698.
24. Adams H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups. Circulation 2007, 115:e478-e534.
25. Wojner-Alexander A.W., Garami Z., Chernyshev O.Y., et al. Heads down: Flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005, 64:1354-1357.
26. De Georgia M., Patel V. Critical care management in acute ischemic stroke. J Neurointerv Surg 2011, 3:34-37.
27. Godoy D.A., Di Napoli M., Rabinstein A.A. Treating hyperglycemia in neurocritical patients: Benefits and perils. Neurocrit Care 2010, 13:425-438.
28. Leontiadis G.I., Yuan Y., Howden C.W. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am 2011, 21:637-656.
29. Orken D.N., Kenangil G., Ozkurt H., et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist 2009, 15:329-331.
30. Ansari S., Rahman M., McConnell D.J., et al. Recanalization therapy for acute ischemic stroke, part 2: Mechanical intra-arterial technologies. Neurosurg Rev 2011, 34:11-20.
31. Kase C.S., Furlan A.J., Wechsler L.R., et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The proact II trial. Neurology 2001, 57:1603-1610.
32. Nogueira R.G., Yoo A.J., Buonanno F.S., et al. Endovascular approaches to acute stroke, part 2: A comprehensive review of studies and trials. Am J Neuroradiol 2009, 30:859-875.
33. Lawson M.F., Velat G.J., Fargen K.M., et al. Interventional neurovascular disease: Avoidance and management of complications and review of the current literature. J Neurosurg Sci 2011, 55:233-242.
34. Kaufmann T.J., Huston J., Mandrekar J.N., et al. Complications of diagnostic cerebral angiography: Evaluation of 19,826 consecutive patients. Radiology 2007, 243:812-819.
35. Samaniego E.A., Dabus G., Linfante I. Avoiding complications in neurosurgical interventional procedures. J Neurosurg Sci 2011, 55:71-80.
36. Wanitschek M.M., Suessenbacher A., Dörler J., et al. Safety and efficacy of femoral artery closure with the femoseal(r) device after coronary angiography using a 7 French sheath. Perfusion 2011, 26:447-452.
37. Trisnohadi H.B. Rapid hemostasis of arterial puncture sites with angio-seal in patients undergoing percutaneous coronary intervention. Acta Med Indones 2005, 37:87-90.
38. Penney C.L. Learning how to remove femoral sheaths. Nursing 1995, 25. 32QQ-32SS.
39. Schickel S., Cronin S.N., Mize A., et al. Removal of femoral sheaths by registered nurses: Issues and outcomes. Crit Care Nurse 1996, 16:32-36.
40. O'Neill W.W. Risk of bleeding after elective percutaneous coronary intervention. N Engl J Med 2006, 355:1058-1060.
41. Lubavin B.V. Retroperitoneal hematoma as a complication of coronary angiography and stenting. Am J Emerg Med 2004, 22:236-238.
42. Kikuchi I., Inoue S., Sakaguchi E. Pseudoaneurysm as a complication of angiography. J Dermatol 1985, 12:534-536.
43. Ferguson J.D., Whatling P.J., Martin V., et al. Ultrasound guided percutaneous thrombin injection of iatrogenic femoral artery pseudoaneurysms after coronary angiography and intervention. Heart 2001, 85:E5.
44. Pannu N., Wiebe N., Tonelli M., et al. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006, 295:2765-2779.
45. Barrett B.J., Parfrey P.S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006, 354:379-386.
46. Birck R., Krzossok S., Markowetz F., et al. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003, 362:598-603.
47. Lima F.O., Lev M.H., Levy R.A., et al. Functional contrast-enhanced ct for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. Am J Neuroradiol 2010, 31:817-821.
48. Mantese V.A., Timaran C.H., Chiu D., et al. The carotid revascularization endarterectomy versus stenting trial (crest): Stenting versus carotid endarterectomy for carotid disease. Stroke 2010, 41:S31-S34.
49. Blacker D.J. In-hospital stroke. Lancet Neurol 2003, 2:741-746.
50. Tedesco M.M., Dalman R.L., Zhou W., et al. Reduction of postprocedure microemboli following retrospective quality assessment and practice improvement measures for carotid angioplasty and stenting. J Vasc Surg 2009, 49:607-612. discussion 612-603.
51. Schnaudigel S., Gröschel K., Pilgram S.M., et al. New brain lesions after carotid stenting versus carotid endarterectomy: A systematic review of the literature. Stroke 2008, 39:1911-1919.
52. Brott T.G., Hobson R.W., Howard G., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010, 363:11-23.
53. Klijn C.J., Kappelle L.J. Haemodynamic stroke: Clinical features, prognosis, and management. Lancet Neurol 2010, 9:1008-1017.
54. Cloft H.J., Jensen M.E., Kallmes D.F., et al. Arterial dissections complicating cerebral angiography and cerebrovascular interventions. Am J Neuroradiol 2000, 21:541-545.
55. Larrue V., von Kummer R.R., Müller A., et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian acute stroke study (Ecass II). Stroke 2001, 32:438-441.
56. Goldstein J.N., Marrero M., Masrur S., et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol 2010, 67:965-969.
57. Larrue V., von Kummer R., del Zoppo G., et al. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European cooperative acute stroke study. Stroke 1997, 28:957-960.
58. Wahlgren N., Ahmed N., Eriksson N., et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe implementation of thrombolysis in stroke-monitoring study (Sits-Most). Stroke 2008, 39:3316-3322.
59. Tanne D., Kasner S.E., Demchuk A.M., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA stroke survey. Circulation 2002, 105:1679-1685.
60. Kidwell C.S., Saver J.L., Carneado J., et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002, 33:717-724.
61. Demchuk A.M., Morgenstern L.B., Krieger D.W., et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34-39.
62. Lansberg M.G., Albers G.W., Wijman C.A. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: A review of the risk factors. Cerebrovasc Dis 2007, 24:1-10.
63. Engelter S.T., Bonati L.H., Lyrer P.A. Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age-A systematic review across cohort studies. Age Ageing 2006, 35:572-580.
64. Kim D., Ford G.A., Kidwell C.S., et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: A comparison of results in patients younger than 80 years. Am J Neuroradiol 2007, 28:159-163.
65. Palumbo V., Boulanger J.M., Hill M.D., et al. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007, 68:1020-1024.
66. Miller D.J., Simpson J.R., Silver B. Safety of thrombolysis in acute ischemic stroke: A review of complications, risk factors, and newer technologies. Neurohospitalist 2011, 1:138-147.
67. Morgenstern L.B., Hemphill J.C., Anderson C., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010, 41:2108-2129.
68. Kidwell C.S., Saver J.L., Mattiello J., et al. Diffusion-perfusion mri characterization of post-recanalization hyperperfusion in humans. Neurology 2001, 57:2015-2021.